MLchartDataset catalogue

therapy-related acute myeloid leukemia

Term · Oncology and biomedicine · MLC-T-ONC-008644

A type of acute myeloid leukemia (AML) that is caused by previous treatment with chemotherapy or radiation therapy. Therapy-related acute myeloid leukemia is an aggressive (fast-growing) cancer in which there are too many myeloblasts (immature white blood cells) in the blood or bone marrow. Therapy-related acute myeloid leukemia usually occurs within 7 years after treatment. It is more common in adults. Also called t-AML.

Table 1. Record
IdentifierMLC-T-ONC-008644
FieldOncology and biomedicine
Synonymst-AML
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008644",
  "term": "therapy-related acute myeloid leukemia",
  "field": "Oncology and biomedicine",
  "definition": "A type of acute myeloid leukemia (AML) that is caused by previous treatment with chemotherapy or radiation therapy. Therapy-related acute myeloid leukemia is an aggressive (fast-growing) cancer in which there are too many myeloblasts (immature white blood cells) in the blood or bone marrow. Therapy-related acute myeloid leukemia usually occurs within 7 years after treatment. It is more common in adults. Also called t-AML.",
  "synonyms": [
    "t-AML"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/therapy-related-acute-myeloid-leukemia/"
}

Record 16,273 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.